446 related articles for article (PubMed ID: 31720980)
1. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device.
Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L
Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980
[TBL] [Abstract][Full Text] [Related]
2. Role of a mydriasis-free, full-field flicker ERG device in the detection of diabetic retinopathy.
Değirmenci MFK; Demirel S; Batıoğlu F; Özmert E
Doc Ophthalmol; 2018 Dec; 137(3):131-141. PubMed ID: 30334119
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).
Rodriguez-Poncelas A; Miravet-Jiménez S; Casellas A; Barrot-De La Puente JF; Franch-Nadal J; López-Simarro F; Mata-Cases M; Mundet-Tudurí X
Br J Ophthalmol; 2015 Dec; 99(12):1628-33. PubMed ID: 26089211
[TBL] [Abstract][Full Text] [Related]
4. A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval.
Deng X; Li Z; Zeng P; Wang J; Liang J; Lan Y
Front Endocrinol (Lausanne); 2021; 12():632457. PubMed ID: 33912134
[TBL] [Abstract][Full Text] [Related]
5. Retinal vasculature-function correlation in non-proliferative diabetic retinopathy.
Zeng Y; Cao D; Yang D; Zhuang X; Hu Y; He M; Yu H; Wang J; Yang C; Zhang L
Doc Ophthalmol; 2020 Apr; 140(2):129-138. PubMed ID: 31552568
[TBL] [Abstract][Full Text] [Related]
6. Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device.
Fukuo M; Kondo M; Hirose A; Fukushima H; Ikesugi K; Sugimoto M; Kato K; Uchigata Y; Kitano S
Sci Rep; 2016 Nov; 6():36591. PubMed ID: 27824158
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
8. Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy.
Shaikh NF; Vohra R; Balaji A; Azad SV; Chawla R; Kumar V; Venkatesh P; Kumar A
Indian J Ophthalmol; 2021 Nov; 69(11):3218-3224. PubMed ID: 34708776
[TBL] [Abstract][Full Text] [Related]
9. Nonlinearities in the flicker electroretinogram: A tool for studying retinal dysfunction applied to early-stage diabetic retinopathy.
McAnany JJ; Chen YF; Liu K; Park JC
Vision Res; 2019 Aug; 161():1-11. PubMed ID: 31129287
[TBL] [Abstract][Full Text] [Related]
10. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis.
Shi L; Wu H; Dong J; Jiang K; Lu X; Shi J
Br J Ophthalmol; 2015 Jun; 99(6):823-31. PubMed ID: 25563767
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
[TBL] [Abstract][Full Text] [Related]
12. Linking Retinal Microvasculature Features With Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
Bhanushali D; Anegondi N; Gadde SG; Srinivasan P; Chidambara L; Yadav NK; Sinha Roy A
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT519-25. PubMed ID: 27472275
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2-Field and 5-Field Mydriatic Handheld Retinal Imaging in a Community-Based Diabetic Retinopathy Screening Program.
Aquino LAC; Salongcay RP; Alog GP; Locaylocay KB; Saunar AV; Peto T; Silva PS
Ophthalmologica; 2023; 246(3-4):203-208. PubMed ID: 37231995
[TBL] [Abstract][Full Text] [Related]
14. A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.
Maa AY; Feuer WJ; Davis CQ; Pillow EK; Brown TD; Caywood RM; Chasan JE; Fransen SR
J Diabetes Complications; 2016 Apr; 30(3):524-32. PubMed ID: 26803474
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity.
Jacoba CMP; Salongcay RP; Aquino LAC; Salva CMG; Saunar AV; Alog GP; Peto T; Silva PS
Acta Ophthalmol; 2023 Sep; 101(6):670-678. PubMed ID: 36847205
[TBL] [Abstract][Full Text] [Related]
16. [Reduction of retinal light sensitivity in diabetic patients].
Pahor D
Klin Monbl Augenheilkd; 2003 Dec; 220(12):868-72. PubMed ID: 14704945
[TBL] [Abstract][Full Text] [Related]
17. High pulse wave velocity is associated with the severity of diabetic retinopathy in patients with type 2 diabetes.
Liu SC; Chuang SM; Shih HM; Wang CH; Tsai MC; Lee CC
J Investig Med; 2020 Aug; 68(6):1159-1165. PubMed ID: 32595133
[TBL] [Abstract][Full Text] [Related]
18. Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes.
Luu CD; Szental JA; Lee SY; Lavanya R; Wong TY
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):482-6. PubMed ID: 19710418
[TBL] [Abstract][Full Text] [Related]
19. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
[TBL] [Abstract][Full Text] [Related]
20. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
Meer E; Bavinger JC; Yu Y; VanderBeek BL
JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
